| I-028 Salih Benamara Development of a PBPK model to predict monoclonal antibody pharmacokinetics and bioavailability following subcutaneous administration Wednesday 10:20-11:50 |
| I-028 Salih Benamara Development of a PBPK model to predict monoclonal antibody pharmacokinetics and bioavailability following subcutaneous administration Wednesday 10:20-11:50 |